Fintel reports that on November 13, 2025, Chardan Capital maintained coverage of Opus Genetics (NasdaqCM:IRD) with a Buy ...
Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step forward when it comes to treating these complex, multifactorial, ...
Fintel reports that on November 10, 2025, BTIG maintained coverage of SOPHiA GENETICS (NasdaqGS:SOPH) with a Buy ...
EXCLUSIVE: We have all heard of families being more prone to breast cancer, but did you know there are other diseases our ...
It was a very big wake-up call,” Jordan Kruse told The Post. “Life was structured a lot differently than what we expected it ...
Treatment options can vary, and the things that worked on our teenage skin might not be as effective later in life. “In ...
Age-related macular degeneration (AMD) is a leading cause of vision loss in those over 50, with genetics playing a ...
The private medical services operator MedLife increased its turnover by 19.5% in the first nine months of the year, to RON ...
Amanda LaValle pushed for her daughter to get genetic testing. When she learns that her daughter is one of only six people in ...
With more than 250 peer-reviewed papers published in several high-impact journals, Katalin Susztak, MD, PhD, has opened the ...
Tempus AI stands out as a leader in healthcare AI, showing strong execution and robust Q3 results despite recent stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback